Differentiate patients with silent (painless) thyroiditis from those with thyrotoxicosis factitia which results from surreptitious thyroid hormone intake
Evaluate therapeutic response to treatment of nontoxic, diffuse and nodular goiter
Limiting factor of serum thyroglobulin (Tg) measurements is presence of Tg autoantibodies which may cause false highs or lows
Results obtained with different assay methods or kits cannot be used interchangeably
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Published Guidelines. 2002. (Accessed 11 Jan 2008) (Link to resource)
Screening for thyroid disease: recommendation statement. United States Preventive Services Task Force - Independent Expert Panel. 1996 (revised 2004 Jan 20). 7 pages. NGC:003266
(Link to NGC)
General References
Mandel SJ.Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects.Best Pract Res Clin Endocrinol Metab. 2004;18(2):213-224. (Link to PubMed)
Weetman AP.Autoimmune thyroid disease.Autoimmunity. 2004;37(4):337-340. (Link to PubMed)
Weetman AP.Non-thyroid autoantibodies in autoimmune thyroid disease.Best Pract Res Clin Endocrinol Metab. 2005;19(1):17-32. (Link to PubMed)
References from the ARUP Institute for Clinical and Experimental Pathology®
La'ulu SL, Slev PR, Roberts WL.Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays.Clin Chim Acta. 2007;376(1-2):88-95. (Link to PubMed)
Reviewed by
Meikle, A. Wayne, M.D. Medical Director, RIA and Endocrinology at ARUP Laboratories; Professor of Internal Medicine and Pathology, University of Utah
Comprehensive Review: July 2008
Last Update: July 2008